April 4, 2007 — Stereotaxis, Inc. has announced that its partnered magnetically enabled 8mm ablation catheter has received FDA approval and will soon be commercially available in the U.S. Two leading European electrophysiology centers have been building successful clinical experience using this catheter to treat atrial cardiac arrhythmias.
April 4, 2007 — Volcano Corp. and ev3 Inc. have announced they have entered into a joint marketing and distribution ...
Cardica Inc. has announced that it has received FDA 510(k) clearance to market its C-Port Flex A Anastomosis System in ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
April 4, 2007 — Vital Images, Inc., a leading provider of enterprise-wide advanced visualization and analysis software ...
April 4, 2007 — Immersion Medical has updated its endovascular platform with features that allow it to simulate a wider ...
April 4, 2007 — A Japanese study has shown that people who take statins and also consume omega-3 fatty acids, typically ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
April 3, 2007 — GE Healthcare and Volcano Corp. have successfully implemented, at multiple sites, Innova IVUS, the world's only fully Integrated IVUS and Cath Lab system. An exclusive collaboration between Volcano Corp. and GE Healthcare made implementation of the fully integrated intravascular ultrasound system for the cath lab and interventional suite possible.
April 3, 2007 — Medicare has announced it will approve additional hospitals for ventricular assist device implantations ...
April 3, 2007 — Cardiovascular Associates, Kingsport, TN, has announced it is studying a medical device in patients to ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
April 3, 2007 —FoxHollow Technologies Inc. has announced it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration for its NightHawk Plaque Excision System. The intended use of the NightHawk System is in the evaluation of peripheral vascular morphology.
April 2, 2007 — Mount Sinai Medical Center, Miami Beach, FL, has implanted one of the first of a new device intended to ...
April 2, 2007 — Cordis Corp. has announced today the start of the pivotal trial for the ExoSeal Vascular Closure Device ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
April 2, 2007 — CardioMEMS Inc. has announced the FDA has cleared the EndoSure AAA Wireless Pressure Measurement System for measuring intrasac pressure during thoracic aortic aneurysm (TAA) repair.
Dr. Nabil Dib, M.D., M.Sc., director of Cardiovascular Cell Therapy at University of California San Diego, reported how 23 patients in an FDA trial were safely transformed from advanced heart failure to recovery, during ACC 2007.
The ImageGrid by Candelis Inc. is a line of Digital Imaging and Communications in Medicine (DICOM) industry-standard ...
April 03, 2007
